We found that C16 inhibited the phosphorylation of PKR and the subsequent activation of the PKR/eIF2α pathway in the WD mouse model, all the while demonstrating a beneficial impact on synaptic functional indicators. The gene discussed is EIF2A; the disease is Wilson disease.